{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:02:41Z","timestamp":1719187361078},"reference-count":91,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2011,9,30]]},"DOI":"10.2217\/fon.11.84","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T19:42:24Z","timestamp":1316115744000},"page":"1101-1112","source":"Crossref","is-referenced-by-count":7,"title":["Treatment Algorithms for Mature T-Cell and Natural Killer-Cell Neoplasms"],"prefix":"10.1080","volume":"7","author":[{"given":"Eric","family":"Tse","sequence":"first","affiliation":[{"name":"Department of Medicine, Queen Mary Hospital, Hong Kong."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yok-Lam","family":"Kwong","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen Mary Hospital, Hong Kong."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,9,15]]},"reference":[{"key":"e_1_3_2_3_1_1","first-page":"158","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2008","unstructured":"Jaffe ES , HarrisNL, SteinH, CampoE, PileriSA, SwerdlowSH. Introduction and overview of the classification of the lymphoid neoplasms. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France158\u2013166 (2008)."},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008265532487"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70265-7"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.1.284.284"},{"key":"e_1_3_2_3_5_1","first-page":"3509","article-title":"Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.","volume":"94","author":"Falini B","year":"1999","unstructured":"Falini B , PulfordK, PucciariniAet al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 94, 3509\u20133515 (1999).","journal-title":"Blood"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.4.2312"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403955"},{"key":"e_1_3_2_3_8_1","first-page":"306","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Pileri SA","year":"2008","unstructured":"Pileri SA , WeisenburgerDD, SngIet al. Peripheral T-cell lymphoma, not otherwise specified. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNL, JaffeESet al. (Eds). International Agency for Research on Cancer. Lyon, France306\u2013308 (2008)."},{"key":"e_1_3_2_3_9_1","first-page":"309","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Dogan A","year":"2008","unstructured":"Dogan A , GaulardP, JaffeES, RalfkiaerE, Muller-HermelinkHK. Angioimmunoblastic T-cell lymphoma. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France309\u2013311 (2008)."},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm265"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0494-8"},{"key":"e_1_3_2_3_12_1","first-page":"285","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Chan JKC","year":"2008","unstructured":"Chan JKC , Quintanilla-MartinezL, FerryJA, PehSC. Extranodal NK\/T-cell lymphoma, nasal type. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France285\u2013288 (2008)."},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4197"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1401"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.1384"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp418"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609045720"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn022"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08329.x"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.332"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32833d58d9"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.4870"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04203.x"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1366"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.050"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-105759"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08003.x"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.12.6219"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.4628"},{"key":"e_1_3_2_3_33_1","unstructured":"Mason DY HarrisNL DelsolGet al. Anaplastic large cell lymphoma ALK-negative. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH CampoE HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon France 317\u2013319 (2008)."},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"e_1_3_2_3_35_1","first-page":"289","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Isaacson PG","year":"2008","unstructured":"Isaacson PG , ChottA, OttG, SteinH. Enteropathy-associated T-cell lymphoma. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France289\u2013291 (2008)."},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.795"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh427"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.026"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231324"},{"key":"e_1_3_2_3_40_1","first-page":"296","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Ralfkiaer E","year":"2008","unstructured":"Ralfkiaer E , CerroniL, SanderCA, SmollerBR, WillemzeR. Mycosis fungoides. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France296\u2013298 (2008)."},{"key":"e_1_3_2_3_41_1","first-page":"289","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Ralfkiaer E","year":"2008","unstructured":"Ralfkiaer E , WillemzeR, WhittakerSJ. Sezary syndrome. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France289\u2013299 (2008)."},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-202895"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.949"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00553-1"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90241-4"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.80"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.2.165"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70112-U"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30058-3"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90282-0"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02704.x"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10706"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2386"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-025999"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190903216770"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08415.x"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09230.x"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.6.727"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705968"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3241"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8301"},{"key":"e_1_3_2_3_64_1","first-page":"300","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Raflkiaer E","year":"2008","unstructured":"Raflkiaer E , WillemzeR, PaulliM, KadinME. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France300\u2013301 (2008)."},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3653"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90442-9"},{"key":"e_1_3_2_3_67_1","first-page":"276","volume-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Chan JKC","year":"2008","unstructured":"Chan JKC , JaffeES, RalfkiaerE, KoYH. Aggressive NK-cell leukemia. In: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. SwerdlowSH, CampoE, HarrisNLet al. (Eds). International Agency for Research on Cancer. Lyon, France276\u2013277 (2008)."},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh143"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02916-4"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.599"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8295"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8592"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000067873"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983387"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00768.x"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.239"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05651.x"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.1291"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6150"},{"key":"e_1_3_2_3_81_1","unstructured":"Piekarz RL FryeR PrinceHMet al. Phase II trial of romidepsin in patients with peripheral T-cell lymphoma. Blood (2011) (Epub ahead of print)."},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4262"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01102.x"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.0766"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404767"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.6688"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp508"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.426"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8554"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0331"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.11.84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:41:27Z","timestamp":1719124887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.11.84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,15]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9,30]]}},"alternative-id":["10.2217\/fon.11.84"],"URL":"https:\/\/doi.org\/10.2217\/fon.11.84","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,15]]}}}